kabutan

Kidswell Bio Corporation, The Current Fiscal Year's Net Income to Narrow

Tue Nov 12, 2024 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE-G] announced its financial results after the market closed on November 12th (16:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 241 million yen (compared to a loss of 780 million yen in the previous period non-consolidated).

In addition, the consolidated net loss for the full year further decrease to loss of 950 million yen (compared to a loss of 1.42 billion yen in the previous period non-consolidated).

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated net loss for the October to March period (second half) is expected to expand to a loss of 709 million yen (compared to a loss of 642 million yen in the previous period non-consolidated).

In the most recent three-month period, from July to September (2Q), the consolidated net loss improved to a deficit of loss of 65 million yen (compared to a loss of 310 million yen in the previous period non-consolidated). The operating profit/loss margin drastically improved from -49.3% in the same period last year to -8.2%.

Note: Since the current fiscal year, the company has transitioned to consolidated financial statements.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 1,116 11 -42 -42 -1.4 ー Nov 8, 2022 J-GAAP
Apr - Sep, 2023 581 -719 -744 -780 -24.1 ー Nov 8, 2023 J-GAAP
Apr - Sep, 2024 1,749 -262 -267 -241 -6.1 ー Nov 12, 2024 J-GAAP
YoY +201.0% +63.6% +64.1% +69.1% +74.7%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － 0 May 14, 2024 J-GAAP
Apr - Sep, 2024 Results 1,749 -262 -267 -241 -6.1 0 Nov 12, 2024 J-GAAP
Revision Rate － － － － －

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 4,000 ー ー ー － 0 May 14, 2024 J-GAAP
Mar, 2025 New 4,000 -1,000 -1,000 -950 -22.1 0 Nov 12, 2024 J-GAAP
Revision Rate 0.0% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 1,850 -616 -645 -642 -18.2 0 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 2,251 -738 -733 -709 -16.5 0 Nov 12, 2024 J-GAAP
YoY +21.7% -19.8% -13.6% -10.4% +9.2%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,776 -550 -624 -657 -20.8 0 May 12, 2023 J-GAAP
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 Guidance 4,000 -1,000 -1,000 -950 -22.1 0 Nov 12, 2024 J-GAAP
YoY +64.5% +25.1% +28.0% +33.2% +45.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 536 -264 -274 -310 -9.6 -49.3 Nov 8, 2023 J-GAAP
Oct - Dec, 2023 985 52 32 33 1.0 5.3 Feb 7, 2024 J-GAAP
Jan - Mar, 2024 865 -668 -677 -675 -19.1 -77.2 May 14, 2024 J-GAAP
Apr - Jun, 2024 482 -158 -176 -176 -4.5 -32.8 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 1,267 -104 -91 -65 -1.6 -8.2 Nov 12, 2024 J-GAAP
YoY +136.4% +60.6% +66.8% +79.0% +82.9%

Related Articles